Laparoscopic Myomectomy: A Minimally Invasive Solution for Uterine Fibroids (original) (raw)

Abstract

Uterine fibroids, also known as leiomyomas, are common benign tumors affecting women of reproductive age. Among the various treatment options available, laparoscopic myomectomy has gained prominence as a minimally invasive surgical approach that offers significant advantages in terms of reduced postoperative pain, shorter recovery times, and preservation of fertility. This abstract provides an overview of the key aspects of laparoscopic myomectomy, including patient selection, surgical techniques, outcomes, and recent advancements. Patient selection plays a pivotal role in achieving successful outcomes in laparoscopic myomectomy. The abstract discusses criteria for selecting appropriate candidates based on factors such as the size, location, and number of fibroids, as well as the patient's reproductive goals. It underscores the importance of individualized treatment plans and thorough preoperative evaluation. The surgical techniques employed in laparoscopic myomectomy, including the use of power morcellation or manual extraction for fibroid removal, are detailed to provide a comprehensive understanding of the procedure. The abstract highlights the benefits of laparoscopy, such as smaller incisions, reduced postoperative pain, and faster recovery. Clinical outcomes associated with laparoscopic myomectomy are also discussed, emphasizing symptom relief, improved quality of life, and the potential for successful pregnancies post-surgery. Potential complications and their management are addressed, underscoring the significance of surgical expertise in minimizing adverse events. Furthermore, recent advancements in laparoscopic myomectomy, such as the use of advanced energy sources, three-dimensional imaging, and robotic-assisted techniques, are highlighted. These innovations have contributed to enhancing the precision and success rates of the procedure while minimizing potential risks. In conclusion, laparoscopic myomectomy has emerged as a highly effective and minimally invasive approach to address uterine fibroids, providing significant benefits for both patients and gynecological surgeons. This abstract provides an overview of the key aspects and recent advancements in this field, underlining its potential to improve the quality of life and reproductive outcomes for women affected by uterine fibroids.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (45)

  1. AAGL Advancing Minimally Invasive Gynecology Worldwide. AAGL practice report: Morcellation during uterine tissue extraction. J Minim Invasive Gynecol. 2014;21:517-30.
  2. ACOG Committee Opinion No. 770: Uterine morcellation for presumed leiomyomas. Obstet Gynecol. 2019;133:e238-48.
  3. American Cancer Society (ACS). (2021). Survival rates for uterine sarcoma. [online] Available from https://www.cancer.org/ cancer/uterine-sarcoma/detection-diagnosis-staging/survival- rates.html. [Last accessed May, 2021].
  4. Banas T, Klimek M, Fugiel A, Skotniczny K. Spontaneous uterine rupture at 35 weeks' gestation, 3 years after laparoscopic myomectomy, without signs of fetal distress. J Obstet Gynaecol Res. 2005;31:527-30.
  5. Brölmann H, Tanos V, Grimbizis G, Ind T, Philips K, van den Bosch T, et al. Options on fibroid morcellation: a literature review. Gynecol Surg. 2015;12:3-15.
  6. Desai VB, Wright JD, Schwartz PE, Gross CP, Xu X. In reply. Obstet Gynecol. 2018;132:519-20.
  7. Dubuisson J, Fauconnier A, Deffarges J, Norgaard C, Kreiker G, Chapron C. Pregnancy outcome and deliveries following laparoscopic myomectomy. Hum Reprod. 2000;15:869-73.
  8. Dubuisson JB, Fauconnier A, Chapron C, Kreiker G, Norgaard C. Reproductive outcome after laparoscopic myomectomy in infertile women. J Reprod Med. 2000;45:23-30.
  9. Einstein MH, Barakat RR, Chi DS, Sonoda Y, Alektiar KM, Hensley ML, et al. Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease. Int J Gynecol Cancer. 2008;18:1065-70.
  10. Farmer RM, Kirschbaum T, Potter D, Strong TH, Medearis AL. Uterine rupture during trial of labour after previous cesarean section. Am J Obstet Gynecol. 1991;65:996-1001.
  11. Flamm BL, Goings JR, Liu Y, Wolde-Tsadik G. Elective repeat cesarean delivery versus trial of labor: a prospective multicenter study. Obstet Gynecol. 1994;83:927-32.
  12. Glaser LM, Friedman J, Tsai S, Chaudhari A, Milad M. Laparoscopic myomectomy and morcellation: a review of techniques, outcomes, and practice guidelines. Best Pract Res Clin Obstet Gynaecol. 2018;46:99-112.
  13. Golan D, Aharoni A, Gonen R, Boss Y, Sharf M. Early spontaneous rupture of the post myomectomy gravid uterus. Int J Gynaecol Obstet. 1990;31:167-70.
  14. Grande N, Catalano GF, Ferrari S, Marana R. Spontaneous uterine rupture at 27 weeks of pregnancy after laparoscopic myomectomy. J Minim Invasive Gynecol. 2005;12:301.
  15. Hensley ML, Leitao MM. (2021). Treatment and prognosis of uterine leiomyosarcoma. [online] Available from https://www. uptodate.com/contents/treatment-and-prognosis-of-uterine- leiomyosarcoma. [Last accessed May, 2021].
  16. Hurst BS, Matthews ML, Marshburn PB. Laparoscopic myo- mectomy for symptomatic uterine myomas. Fertil Steril. 2005;83:1-23.
  17. Kumakiri J, Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Itoh S, et al. Pregnancy and delivery after laparoscopic myomectomy. J Minim Invasive Gynecol. 2005;12:241-6.
  18. Landi S, Fiaccavento A, Zaccoletti R, Barbieri F, Syed R, Minelli L. Pregnancy outcomes and deliveries after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 2003;10:177-81.
  19. Lieng M, Istre O, Langebrekke A. Uterine rupture after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 2004;11:92-3.
  20. Lynam S, Young L, Morozov V, Rao G, Roque DM. Risk, risk reduction and management of occult malignancy diagnosed after uterine morcellation: a commentary. Womens Health (Lond). 2015;11:929-44.
  21. Malin JL, Kahn KL, Adams J, Kwan L, Laouri M, Ganz PA. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst. 2002;94:835-44.
  22. Moore BJ, White S, Washington R, Coenen N, Elixhauser A. Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: The AHRQ Elixhauser Comorbidity Index. Med Care. 2017;55:698-705.
  23. Mowers EL, Skinner B, McLean K, Reynolds RK. Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice. J Minim Invasive Gynecol. 2015;22:601-6.
  24. Nielsen TF, Ljungblad U, Hagberg H. Rupture and dehiscence of cesarean section during pregnancy and delivery. Am J Obstet Gynecol. 1989;160:569-73.
  25. Nkemayim DC, Hammadeh ME, Hippach M, Mink D, Schmidt W. Uterine rupture in pregnancy subsequent to previous laparoscopic electromyolysis: case report and review of the literature. Arch Gynecol Obstet. 2000;264:154-6.
  26. Oduyebo T, Rauh-Hain AJ, Meserve EE, Seidman MA, Hinchcliff E, George S, et al. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Gynecol Oncol. 2014;132:360-5.
  27. Ozeren M, Ulusov M, Uvanik E. First-trimester spontaneous uterine rupture after traditional myomectomy: case report. Isr J Med Sci. 1997;33:752-3.
  28. Pelosi MA, Pelosi MA. Spontaneous uterine rupture at thirty- three weeks subsequent to previous superficial laparoscopic myomectomy. Am J Obstet Gynecol. 1997;177:1547-9.
  29. Phelan JP, Clark SL, Diaz F, Paul RH. Vaginal birth after cesarean. Am J Obstet Gynecol. 1987;157:1510-15.
  30. Pirracchio R, Resche-Rigon M, Chevret S. Evaluation of the propensity score methods for estimating marginal odds ratios in case of small sample size. BMC Med Res Methodol. 2012;12:70.
  31. Pisarska MD, Carson SA. Incidence and risk factors for ectopic pregnancy. Clin Obstet Gynecol. 1999;42:2-8.
  32. Raine-Bennett T, Tucker LY, Zaritsky E, Littell RD, Palen T, Neugebauer R, et al. Occult uterine sarcoma and leiomyosarcoma: incidence of and survival associated with morcellation. Obstet Gynecol. 2016;127:29-39.
  33. Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379:1895-904.
  34. Raspagliesi F, Maltese G, Bogani G, Fucà G, Lepori S, De Iaco P, et al. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: a retrospective MITO group study. Gynecol Oncol. 2017;144:90-5.
  35. Roopnarinesingh S, Suratsingh J, Roopnarinesingh A. The obstetric outcome of patients with previous myomectomy or hysterotomy. West Indian Med J. 1985;34:59-62.
  36. Seagle BLL, Sobecki-Rausch J, Strohl AE, Shilpi A, Grace A, Shahabi S. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study. Gynecol Oncol. 2017;145:61-70.
  37. Seinera P, Farina C, Todros T. Laparoscopic myomectomy and subsequent pregnancy: results in 54 patients. Hum Reprod. 2000;15:1993-6.
  38. Siedhoff MT, Doll KM, Clarke-Pearson DL, Rutstein SE. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications. Am J Obstet Gynecol. 2017;216:259.e1-6.
  39. Sizzi O, Manganaro L, Rossetti A, Saldari M, Florio G, Loddo A, et al. Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations. Eur J Obstet Gynecol Reprod Biol. 2018;220:30-8.
  40. Stewart EA. (2020). Uterine fibroids (leiomyomas): Differentiating fibroids from uterine sarcomas. [online] Available from https:// www.uptodate.com/contents/uterine-fibroids-leiomyomas- differentiating-fibroids-from-uterine-sarcomas. [Last accessed May, 2021].
  41. Stringer NH, Strassner HT, Lawson L, Oldham L, Estes C, Edwards M, et al. Pregnancy outcomes after laparoscopic myomectomy with ultrasonic energy and laparoscopic suturing of the endometrial cavity. J Am Assoc Gynecol Laparosc. 2001;8:129-36.
  42. Tantitamit T, Huang KG, Manopunya M, Yen CF. Outcome and management of uterine leiomyosarcoma treated following surgery for presumed benign disease: review of literature. Gynecol Minim Invasive Ther. 2018;7:47-55.
  43. Tissue Extraction Task Force Members. Morcellation during uterine tissue extraction: an update. J Minim Invasive Gynecol. 2018;25:543-50.
  44. Tulandi T, Ferenczy A. Biopsy of uterine leiomyomata and frozen sections before laparoscopic morcellation. J Minim Invasive Gynecol. 2014;21:963-6.
  45. Wright JD, Cui RR, Wang A, Chen L, Tergas AI, Burke WM, et al. Economic and survival implications of use of electric power morcellation for hysterectomy for presumed benign gynecologic disease. J Natl Cancer Inst. 2015;107:djv251.